Robert Louis Hoffman

Person

Kalamazoo, MI, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pyridinone MK2 inhibitors and uses thereof
- Patent number 12,139,462
- Issue date Nov 12, 2024
- XinThera, Inc.
- Robert L. Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Composition for the treatment of COVID-19 infection, and a method o...
- Patent number 12,023,370
- Issue date Jul 2, 2024
- Anticancer Inc.
- Qinghong Han
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Substituted pyridines as PARP1 inhibitors
- Patent number 12,006,322
- Issue date Jun 11, 2024
- Xin Thera, Inc.
- Robert L. Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 11,987,574
- Issue date May 21, 2024
- XinThera, Inc.
- Lynnie Trzoss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PARP1 inhibitors and uses thereof
- Patent number 11,939,329
- Issue date Mar 26, 2024
- XinThera, Inc.
- Robert L. Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for the treatment of COVID-19
- Patent number 11,926,642
- Issue date Mar 12, 2024
- Pfizer Inc.
- Robert Steven Kania
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition for preventing age-related metabolic and tissue degener...
- Patent number 11,873,519
- Issue date Jan 16, 2024
- Qinghong Han
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Transplantation method to increase the establishment rate of human...
- Patent number 11,871,731
- Issue date Jan 16, 2024
- Anticancer, Inc.
- Robert M. Hoffman
- G01 - MEASURING TESTING
Information Patent Grant
Azetidine and pyrrolidine PARP1 inhibitors and uses thereof
- Patent number 11,802,128
- Issue date Oct 31, 2023
- XINTHERA, INC.
- Robert L. Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyridines as PARP1 inhibitors
- Patent number 11,795,173
- Issue date Oct 24, 2023
- XINTHERA, INC.
- Robert L Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK2 inhibitors
- Patent number 11,773,082
- Issue date Oct 3, 2023
- Pfizer Inc.
- Douglas Carl Behenna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK2 inhibitors
- Patent number 11,718,603
- Issue date Aug 8, 2023
- Pfizer Inc.
- Douglas Carl Behenna
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridinone MK2 inhibitors and uses thereof
- Patent number 11,685,719
- Issue date Jun 27, 2023
- XINTHERA, INC.
- Robert L. Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 11,680,056
- Issue date Jun 20, 2023
- XINTHERA, INC.
- Lynnie Trzoss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK2/4/6 inhibitors
- Patent number 11,396,512
- Issue date Jul 26, 2022
- Pfizer Inc.
- Douglas Carl Behenna
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Orally administered composition of methioninase enzyme
- Patent number 11,371,036
- Issue date Jun 28, 2022
- Qinghong Han
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CDK2 inhibitors
- Patent number 11,014,911
- Issue date May 25, 2021
- Pfizer Inc.
- Douglas Carl Behenna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Orally administered composition to lower serum methionine levels an...
- Patent number 11,001,826
- Issue date May 11, 2021
- Anticancer, Inc.
- Qinghong Han
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CDK2/4/6 inhibitors
- Patent number 10,800,783
- Issue date Oct 13, 2020
- Pfizer Inc.
- Douglas Carl Behenna
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cycloalkyl-linked diheterocycle derivatives
- Patent number 10,676,471
- Issue date Jun 9, 2020
- Pfizer Inc.
- Aaron Craig Burns
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK2/4/6 inhibitors
- Patent number 10,233,188
- Issue date Mar 19, 2019
- Pfizer Inc.
- Kevin Daniel Freeman-Cook
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cycloalkyl-linked diheterocycle derivatives
- Patent number 10,125,130
- Issue date Nov 13, 2018
- Pfizer Inc.
- Aaron Craig Burns
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic derivatives for the treatment of diseases
- Patent number 9,133,215
- Issue date Sep 15, 2015
- Pfizer Inc.
- Simon Bailey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic derivatives for the treatment of diseases
- Patent number 8,680,111
- Issue date Mar 25, 2014
- Pfizer Inc.
- Simon Bailey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as CRF1 receptor antagonists
- Patent number 7,250,418
- Issue date Jul 31, 2007
- Pfizer Inc.
- Jeffrey W. Corbett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrimidine derivatives
- Patent number 7,087,617
- Issue date Aug 8, 2006
- Pfizer Inc.
- Jeffrey W. Corbett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted aryl 1, 4-pyrazine derivatives
- Patent number 7,041,672
- Issue date May 9, 2006
- Pfizer Inc.
- Patrick R. Verhoest
- G01 - MEASURING TESTING
Information Patent Grant
Substituted pyrimidinones and pyrimidinthiones
- Patent number 7,015,229
- Issue date Mar 21, 2006
- Pfizer Inc.
- Jian-Min Fu
- G01 - MEASURING TESTING
Information Patent Grant
Substituted aryl 1,4-pyrazine derivatives
- Patent number 6,992,087
- Issue date Jan 31, 2006
- Pfizer Inc.
- Patrick R. Verhoest
- G01 - MEASURING TESTING
Information Patent Grant
Substituted pyrazine derivatives
- Patent number 6,964,965
- Issue date Nov 15, 2005
- Pharmacia & Upjohn
- Jeffrey W. Corbett
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED PYRIDINES AS PARP1 INHIBITORS
- Publication number 20240400569
- Publication date Dec 5, 2024
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PARP1 INHIBITORS AND USES THEREOF
- Publication number 20240368162
- Publication date Nov 7, 2024
- Xinthera, Inc.
- Qing DONG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK2 INHIBITORS
- Publication number 20240294506
- Publication date Sep 5, 2024
- Pfizer Inc.
- Douglas Carl Behenna
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHA4 BETA7 INEGRIN ANTAGONISTS AND USES THEREOF
- Publication number 20240279214
- Publication date Aug 22, 2024
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF AN MK2 INHIBITOR
- Publication number 20240182449
- Publication date Jun 6, 2024
- Xinthera, Inc.
- Jing LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF A PARP1 INHIBITOR
- Publication number 20240174669
- Publication date May 30, 2024
- Xinthera, Inc.
- Jayachandra P. REDDY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD AND COMPOSITION FOR THE TREATMENT OF CANCER
- Publication number 20240115673
- Publication date Apr 11, 2024
- Yutaro Kubota
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUBSTITUTED PYRIDINES AS PARP1 INHIBITORS
- Publication number 20240109904
- Publication date Apr 4, 2024
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDINONE MK2 INHIBITORS AND USES THEREOF
- Publication number 20230382864
- Publication date Nov 30, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20230373969
- Publication date Nov 23, 2023
- Xinthera, Inc.
- Lynnie TRZOSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRIDINES AS PARP1 INHIBITORS
- Publication number 20230348473
- Publication date Nov 2, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20230265076
- Publication date Aug 24, 2023
- Xinthera, Inc.
- Lynnie TRZOSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PARP1 INHIBITORS AND USES THEREOF
- Publication number 20230234952
- Publication date Jul 27, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF
- Publication number 20230203033
- Publication date Jun 29, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Benzisoxazole Sulfonamide Derivatives
- Publication number 20230174522
- Publication date Jun 8, 2023
- Pfizer Inc.
- Ylva Elisabet Bergman Bozikis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Inhibiting SARS-CoV-2 Replication and Treating Corona Vi...
- Publication number 20230157998
- Publication date May 25, 2023
- Pfizer Inc.
- Padmavani Bezawada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF
- Publication number 20230159525
- Publication date May 25, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PARP1 INHIBITORS AND USES THEREOF
- Publication number 20230128041
- Publication date Apr 27, 2023
- Xinthera, Inc.
- Lynnie TRZOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of Treating COVID-19
- Publication number 20230105838
- Publication date Apr 6, 2023
- Pfizer Inc.
- Robert Louis Hoffman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDINONE MK2 INHIBITORS AND USES THEREOF
- Publication number 20230053465
- Publication date Feb 23, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20220402892
- Publication date Dec 22, 2022
- Xinthera, Inc.
- Lynnie TRZOSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PARP1 INHIBITORS AND USES THEREOF
- Publication number 20220348574
- Publication date Nov 3, 2022
- Xinthera, Inc.
- Lynnie TRZOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORALLY ADMINISTERED COMPOSITION TO LOWER SERUM METHIONINE LEVELS AN...
- Publication number 20220340891
- Publication date Oct 27, 2022
- Qinghong Han
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CDK2/4/6 Inhibitors
- Publication number 20220324872
- Publication date Oct 13, 2022
- Pfizer Inc.
- Douglas Carl Behenna
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cycloalkyl and Heterocycloalkyl Benzisoxazole Sulfonamide Derivatives
- Publication number 20220251075
- Publication date Aug 11, 2022
- Pfizer Inc.
- Oleg Brodsky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and Methods for the Treatment of COVID-19
- Publication number 20220017548
- Publication date Jan 20, 2022
- Pfizer Inc.
- Robert Steven Kania
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION FOR THE TREATMENT OF COVID-19 INFECTION, AND A METHOD O...
- Publication number 20210330767
- Publication date Oct 28, 2021
- Qinghong Han
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK2 INHIBITORS
- Publication number 20210269425
- Publication date Sep 2, 2021
- Pfizer Inc.
- Douglas Carl Behenna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK2 INHIBITORS
- Publication number 20210261530
- Publication date Aug 26, 2021
- Pfizer Inc.
- Douglas Carl Behenna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORALLY ADMINISTERED COMPOSITION TO LOWER SERUM METHIONINE LEVELS AN...
- Publication number 20210254040
- Publication date Aug 19, 2021
- AntiCancer Inc.
- Qinghong Han
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Robert Louis Hoffman

Person

Patents Grantslast 30 patents

Pyridinone MK2 inhibitors and uses thereof

Composition for the treatment of COVID-19 infection, and a method o...

Substituted pyridines as PARP1 inhibitors

MK2 inhibitors and uses thereof

PARP1 inhibitors and uses thereof

Compounds and methods for the treatment of COVID-19

Composition for preventing age-related metabolic and tissue degener...

Transplantation method to increase the establishment rate of human...

Azetidine and pyrrolidine PARP1 inhibitors and uses thereof

Substituted pyridines as PARP1 inhibitors

CDK2 inhibitors

CDK2 inhibitors

Pyridinone MK2 inhibitors and uses thereof

MK2 inhibitors and uses thereof

CDK2/4/6 inhibitors

Orally administered composition of methioninase enzyme

CDK2 inhibitors

Orally administered composition to lower serum methionine levels an...

CDK2/4/6 inhibitors

Cycloalkyl-linked diheterocycle derivatives

CDK2/4/6 inhibitors

Cycloalkyl-linked diheterocycle derivatives

Macrocyclic derivatives for the treatment of diseases

Macrocyclic derivatives for the treatment of diseases

Compounds as CRF1 receptor antagonists

Substituted pyrimidine derivatives

Substituted aryl 1, 4-pyrazine derivatives

Substituted pyrimidinones and pyrimidinthiones

Substituted aryl 1,4-pyrazine derivatives

Substituted pyrazine derivatives

Patents Applicationslast 30 patents

SUBSTITUTED PYRIDINES AS PARP1 INHIBITORS

PARP1 INHIBITORS AND USES THEREOF

CDK2 INHIBITORS

ALPHA4 BETA7 INEGRIN ANTAGONISTS AND USES THEREOF

CRYSTALLINE FORMS OF AN MK2 INHIBITOR

CRYSTALLINE FORMS OF A PARP1 INHIBITOR

METHOD AND COMPOSITION FOR THE TREATMENT OF CANCER

SUBSTITUTED PYRIDINES AS PARP1 INHIBITORS

PYRIDINONE MK2 INHIBITORS AND USES THEREOF

MK2 INHIBITORS AND USES THEREOF

SUBSTITUTED PYRIDINES AS PARP1 INHIBITORS

MK2 INHIBITORS AND USES THEREOF

PARP1 INHIBITORS AND USES THEREOF

AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF

Benzisoxazole Sulfonamide Derivatives

Methods of Inhibiting SARS-CoV-2 Replication and Treating Corona Vi...

AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF

PARP1 INHIBITORS AND USES THEREOF

Method of Treating COVID-19

PYRIDINONE MK2 INHIBITORS AND USES THEREOF

MK2 INHIBITORS AND USES THEREOF

PARP1 INHIBITORS AND USES THEREOF

ORALLY ADMINISTERED COMPOSITION TO LOWER SERUM METHIONINE LEVELS AN...

CDK2/4/6 Inhibitors

Cycloalkyl and Heterocycloalkyl Benzisoxazole Sulfonamide Derivatives

Compounds and Methods for the Treatment of COVID-19

COMPOSITION FOR THE TREATMENT OF COVID-19 INFECTION, AND A METHOD O...

CDK2 INHIBITORS

CDK2 INHIBITORS

ORALLY ADMINISTERED COMPOSITION TO LOWER SERUM METHIONINE LEVELS AN...